News Focus
News Focus
Followers 20
Posts 2314
Boards Moderated 0
Alias Born 12/13/2009

Re: Investor2014 post# 417022

Friday, 05/26/2023 7:33:32 PM

Friday, May 26, 2023 7:33:32 PM

Post# of 517434

I wonder has anyone here so far managed to make a positive return from buying $AVXL call options



That is of no interest to me since I have not previously bought AVXL call options. I am just now staking out long call options positions with what I believe are very low break-even points due to my perception of a change in AVXL's business fundamentals and my optimism about favorable Rett's EXCELLENCE results as well as hopes for AD

HINT: Today's stock buy. IOVA just received AH an FDA acceptance of its BLA for Lifileucel for treatment of advanced metastatic and nonresectable melanoma. The FDA granted a six month priority review with a PDUFA data of November 25, 2023. No advisory meeting planned by the FDA. IOVA's stock price traded around $28 prior to the initial rejection of the BLA. The stock price closed today at $7.55. If Lifileucel receives accelerated approval, IOVA will have a confirmatory Phase III trial in frontline advance melanoma that is now recruiting. Most recent February 2023 analyst target issued at $30.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News